Silence Therapeutics plc
SLN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479615
No open-market purchases or sales by Silence Therapeutics plc insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $236.2M in total; no superinvestor holds it.
Other share classesSLNCF
Q2 2026 vs. Q1 2026
How the institutions holding Silence Therapeutics plc changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 56 | 72 | +16 |
| Shares | 19.9M | 22.2M | +2.33M (+11.7%) |
| Value | $102.1M | $236.2M | +$134.2M (+131.4%) |
New holders (20)
Institutions that held Silence Therapeutics plc at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Soleus Capital Management, L.P. | 630,000 | $6.92M | 0.24% |
| Balyasny Asset Management LLC | 610,980 | $6.71M | 0.01% |
| Ameriprise Financial Inc | 370,052 | $4.06M | 0.00% |
| SummitTX Capital, L.P. | 326,648 | $3.59M | 0.09% |
| Schonfeld Strategic Advisors LLC | 269,348 | $2.96M | 0.02% |
| Propel Bio Management, LLC | 191,733 | $2.11M | 1.10% |
| Fred Alger Management, LLC | 177,000 | $1.94M | 0.01% |
| Caption Management, LLC | 162,476 | $1.78M | 0.06% |
| Quadrature Capital Ltd | 118,129 | $1.30M | 0.01% |
| Birchview Capital, LP | 71,218 | $782.0K | 0.37% |
| Virtu Financial LLC | 25,641 | $282.0K | 0.01% |
| Trexquant Investment LP | 23,842 | $261.8K | 0.00% |
| Verdad Advisers, LP | 20,400 | $224.0K | 0.21% |
| Scientech Research LLC | 19,133 | $210.1K | 0.17% |
| Renaissance Technologies LLC | 16,930 | $185.9K | 0.00% |
| Arrowpoint Investment Partners (Singapore) Pte. Ltd. | 16,334 | $179.3K | 0.05% |
| Persistent Asset Partners Ltd | 15,170 | $166.6K | 0.05% |
| Axq Capital, LP | 12,566 | $138.0K | 0.02% |
| CenterBook Partners LP | 10,416 | $114.4K | 0.01% |
| Rialto Wealth Management, LLC | 1,021 | $11.2K | 0.00% |
Sold out (4)
Institutions that held Silence Therapeutics plc at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Jones Hill Capital LP | 301,604 | $1.59M |
| Point72 Asset Management, L.P. | 119,711 | $630.9K |
| Dynamic Technology Lab Private Ltd | 10,490 | $55.3K |
| Simplex Trading, LLC | 612 | $3.23K |